CN112121077A - Traditional Chinese medicine lotion for treating hemorrhoids - Google Patents
Traditional Chinese medicine lotion for treating hemorrhoids Download PDFInfo
- Publication number
- CN112121077A CN112121077A CN202011168757.3A CN202011168757A CN112121077A CN 112121077 A CN112121077 A CN 112121077A CN 202011168757 A CN202011168757 A CN 202011168757A CN 112121077 A CN112121077 A CN 112121077A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- treating hemorrhoids
- parts
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 208000014617 hemorrhoid Diseases 0.000 title claims abstract description 28
- 239000006210 lotion Substances 0.000 title claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 235000008113 selfheal Nutrition 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 238000001914 filtration Methods 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 8
- 240000000724 Berberis vulgaris Species 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 7
- 244000179560 Prunella vulgaris Species 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 7
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 7
- 235000010234 sodium benzoate Nutrition 0.000 claims description 7
- 239000004299 sodium benzoate Substances 0.000 claims description 7
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 5
- 241000219784 Sophora Species 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 4
- 240000001949 Taraxacum officinale Species 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 18
- 208000002193 Pain Diseases 0.000 abstract description 8
- 230000036407 pain Effects 0.000 abstract description 8
- 230000008961 swelling Effects 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 230000002588 toxic effect Effects 0.000 abstract description 6
- 239000000203 mixture Substances 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 239000013543 active substance Substances 0.000 abstract 2
- 244000299788 selfheal Species 0.000 abstract 1
- 238000000034 method Methods 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 239000000284 extract Substances 0.000 description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 5
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 241000245665 Taraxacum Species 0.000 description 4
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 4
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 4
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 4
- 235000005493 rutin Nutrition 0.000 description 4
- 229960004555 rutoside Drugs 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000004856 capillary permeability Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 206010014025 Ear swelling Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229960001736 buprenorphine Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000000197 Acute Cholecystitis Diseases 0.000 description 1
- 241000221377 Auricularia Species 0.000 description 1
- 241000133570 Berberidaceae Species 0.000 description 1
- 241001407382 Berberis julianae Species 0.000 description 1
- 240000008286 Berberis poiretii Species 0.000 description 1
- 235000018554 Berberis poiretii Nutrition 0.000 description 1
- 241001407775 Berberis pruinosa Species 0.000 description 1
- 241001073507 Callicarpa Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 206010008614 Cholecystitis acute Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 235000010674 Prunella vulgaris Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002884 effect on inflammation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 201000007772 internal hemorrhoid Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine lotion for treating hemorrhoids, which is characterized by being prepared from the following raw materials in parts by weight: 400 portions of selfheal 200-. The Chinese medicinal composition is prepared by extracting the Chinese medicinal raw materials consisting of the formula to prepare a medicinal active substance, and then preparing the medicinal active substance serving as the raw material according to the conventional technology of pharmaceutics. The functional indications are as follows: the Chinese medicinal lotion has the advantages of clearing away heat and toxic materials, promoting blood circulation, removing blood stasis, relieving swelling and pain, and treating hemorrhoids, and has the advantages of economy, short treatment period, quick response, and no toxic or side effect.
Description
Technical Field
The invention relates to a traditional Chinese medicine lotion for treating hemorrhoids, and belongs to the technical field of traditional Chinese medicines.
Background
Hemorrhoids are common and frequently encountered clinical diseases of anorectal department. Hemorrhoids are divided into 3 types of internal hemorrhoids, external hemorrhoids and mixed hemorrhoids, and clinically, local inflammation, swelling and pain, hematochezia and prolapse are the main symptoms. The surgical excision method has long treatment course and great pain, is not easy to be accepted by patients, and has more formulations of the medicaments for treating the hemorrhoids, the oral medicaments comprise tablets, pills, capsules or granules, the external medicaments comprise suppositories, salves and powder, and the local injections are mainly divided into two types of necrosis agents and hardening agents. The main pharmacodynamics of the oral medicine and the external medicine are inflammation diminishing, bleeding stopping, pain relieving, astringing, corrosion resisting and the like. The traditional Chinese medicine fumigation and washing becomes the main means of treatment with good curative effect and simple and convenient use method.
Disclosure of Invention
Aiming at the technical problems, the invention aims to provide the traditional Chinese medicine lotion for treating the hemorrhoids, which has good curative effect and no toxic or side effect.
In order to achieve the aim, the invention provides a traditional Chinese medicine lotion for treating hemorrhoids, which is characterized by being prepared from the following raw materials in parts by weight: 400 portions of selfheal 200-.
Preferably: the composite material is prepared from the following raw materials in parts by weight: 300 parts of selfheal, 300 parts of dandelion, 250 parts of barberry root and 300 parts of sophora flower bud.
In the scheme, the method comprises the following steps: decocting Spica Prunellae, herba Taraxaci, radix Berberidis and flos Sophorae Immaturus coarse powder in water, filtering, concentrating the decoction, adding sodium benzoate, press filtering, adding distilled water, mixing, and packaging to obtain the final product.
In the scheme, the method comprises the following steps: decocting twice, wherein the water adding amount of each decoction is 10-11 times of the total weight of the dry medicines, and the decocting time is 1-1.5 h.
In the scheme, the method comprises the following steps: the filtrate was concentrated to 1-1.5g crude drug per ml water.
In the scheme, the method comprises the following steps: the addition amount of the sodium benzoate is 0.4-0.6% of the weight of the concentrated solution.
In the scheme, the method comprises the following steps: the distilled water is added according to the weight of the concentrated solution and the equal proportion.
The traditional Chinese medicine lotion belongs to solution type lotion, and has original medicine smell and no mildew, peculiar smell, color change, turbidity and precipitate. The invention is prepared by extracting the traditional Chinese medicine raw materials consisting of the formula to prepare the active pharmaceutical substance, and then taking the active pharmaceutical substance as the raw material according to the conventional technology of pharmaceutics. The functional indications are as follows: the traditional Chinese medicine lotion has the advantages of clearing away heat and toxic materials, promoting blood circulation to remove blood stasis, and relieving swelling and pain, is mainly used for treating hemorrhoids, is economical, short in treatment period, easy to accept by patients, quick in effect, and free of toxic and side effects.
Detailed Description
The invention is further illustrated by the following examples:
example 1
A traditional Chinese medicine for treating hemorrhoids is prepared from 200g of selfheal, 200g of dandelion, 150g of barberry root and 200g of sophora flower bud.
Decocting Spica Prunellae, herba Taraxaci, radix Berberidis and flos Sophorae Immaturus coarse powder with water twice, wherein the amount of water added for each decoction is 10 times of the total weight of the dry medicinal materials, and the decocting time is 1 h. Decocting, filtering, mixing filtrates, concentrating to 750mL, adding 0.4% sodium benzoate, press filtering, adding 750mL distilled water, mixing, subpackaging into 100 mL/bottle, and labeling. When in use, a bottle of the product is taken, diluted to 1500ml by hot water, smoked for 3-5 minutes, and then subjected to hip bath for 30 minutes for 2 times a day. 5-7 days is 1 course of treatment, and 2-3 courses of treatment are generally good.
Example 2
A traditional Chinese medicine for treating hemorrhoids is prepared from 400g of selfheal, 400g of dandelion, 350g of barberry root and 400g of sophora flower bud.
Decocting Spica Prunellae, herba Taraxaci, radix Berberidis and flos Sophorae Immaturus coarse powder with water twice, wherein the amount of water added for each decoction is 11 times of the total weight of the dry medicinal materials, and the decocting time is 1.5 h. Decocting, filtering, mixing filtrates, concentrating to 1000mL, adding 0.6% sodium benzoate, press filtering, adding 1000mL distilled water, mixing, subpackaging into 100 mL/bottle, and labeling. When in use, a bottle of the product is taken, diluted to 1500ml by hot water, smoked for 3-5 minutes, and then subjected to hip bath for 30 minutes for 2 times a day. 5-7 days is 1 course of treatment, and 2-3 courses of treatment are generally good.
Example 3
A Chinese medicinal composition for treating hemorrhoid is prepared from Prunellae Spica 300g, herba Taraxaci 300g, radix Berberidis 250g, and flos Sophorae Immaturus 300 g.
Decocting Spica Prunellae, herba Taraxaci, radix Berberidis and flos Sophorae Immaturus coarse powder with water twice, wherein the amount of water added for each decoction is 11 times of the total weight of the dry medicinal materials, and the decocting time is 1.5 h. Decocting, filtering, mixing filtrates, concentrating to 1000mL, adding 0.5% sodium benzoate, press filtering, adding 1000mL distilled water, mixing, subpackaging into 100 mL/bottle, and labeling. When in use, a bottle of the product is taken, diluted to 1500ml by hot water, smoked for 3-5 minutes, and then subjected to hip bath for 30 minutes for 2 times a day. 5-7 days is 1 course of treatment, and 2-3 courses of treatment are generally good.
Pharmacology and toxicology
1. Study of pharmacodynamics
The invention takes sophora flower bud as a main drug and is combined with berberis poiretii schneid, dandelion and prunella vulgaris. Simple formula, low cost and good curative effect.
The flos Sophorae Immaturus contains rutin (Rut) and quercetin (Que) as effective components, wherein the rutin has pharmacological activities of reducing capillary permeability, resisting inflammation and allergy, and the rutin injected into abdominal cavity of rat has obvious inhibition effect on inflammation process of implanted wool ball; quercetin has dose-dependent anti-hemorrhage and analgesic effects, and rutin also has analgesic effect.
Root of Chinese barberry, name of Chinese medicine. Is root bark or stem bark of Berberis vulgaris L.var.prunifolia (berberis thunb.) kurz, Berberis pruinosa L.var.prunifolia (berberis thunb.) kurz, Callicarpa kurossi et al, belonging to berberidaceae. Root bark can be harvested all year round. Harvesting stems and branches in spring and autumn, scraping the outer skins of the stems and branches, peeling the dark yellow inner skins, and drying in the sun. Bitter taste and cold nature. Has effects of clearing heat, promoting diuresis, and removing blood stasis. Can be used for treating dysentery with bloody stool, jaundice, pharyngalgia, conjunctival congestion, and traumatic injury.
Dandelion has the effects of clearing away heat and toxic materials, inducing diuresis and resolving masses. It can be used for treating acute mastitis, lymphadenitis, lymphoid tuberculosis, furunculosis, acute conjunctivitis, common cold with fever, acute tonsillitis, acute bronchitis, gastritis, hepatitis, cholecystitis, and urinary tract infection.
Spica Prunellae, clears heat and purges fire, improves eyesight, and eliminates stagnation and subsides swelling.
The invention is combined in whole formula and is used for treating hemorrhoids.
1.1 inhibitory Effect of the extract of the present invention on ear swelling of mice caused by xylene
The male Kunming mice 90 were randomly divided into 9 groups of 10 mice each. Examples 1 and 3 two test samples were set to be 0.15g/kg in the low dose group and 0.30g/kg in the high dose group, respectively, and 7 experimental groups of normal saline, tween-80-normal saline, and aspirin. Each group was administered by gavage for 3 days continuously, and after 2h of the last administration (1 h of aspirin administration), 0.05mL of xylene was applied to both the front and back sides of the right ear of the mouse, the cervical vertebra was dislocated and sacrificed after 15min, a punch with a diameter of 9mm was used to punch and sample the same portions of the left and right auricles, weighing was performed in time, the inhibition rate and the swelling degree were calculated, statistical treatment was performed by t-test, and compared with the control group.
The water extract of the invention with the dosage of 0.30g/kg has obvious inhibition effect on mouse ear swelling caused by dimethylbenzene, the inhibition rates are respectively 35.18 percent and 42.14 percent, the ratio of the water extract to negative control group 2 and group 1 is obviously different (P is less than 0.05), and the results are shown in table 1.
Table 1 anti-inflammatory effect of the extract of the invention on swelling of mouse ears by xylene (n-10,
)
p <0.05 compared to tween-80-saline group; p <0.05 compared to saline group
1.2 the extract of the present invention has a significant inhibitory effect on capillary permeability, as shown in Table 2.
Table 2 effect of the extracts of the invention on the permeability of the capillaries in the abdominal cavity of mice (n-10,
)
p <0.05 compared with Tween-80-normal saline
From the above table, it can be seen that the traditional Chinese medicine composition has a significant inhibiting effect on chemical red swelling of the auricularia porch and increased capillary permeability of mice, and can obviously relieve red, swollen and hot symptoms of acute inflammatory reaction.
1.3 analgesic Effect test
The grouping and results are shown in Table 1, the invention (50 or 100 mg. kg)-1Ip) can significantly improve the mouse whizzing stimulus threshold, 100 mg/kg-1The peak effect of the medicine of the invention is 4 mg-kg of Mor (buprenorphine)-1The equivalent, i.e. the potency of the invention (example 3) is about 1/25 for Mor (buprenorphine).
Table 3 increasing effect of Rut on mouse electrical hissing threshold (n 10,
)
p <0.05, P <0.01t test compared to pre-dose
2. Toxicology studies
Acute toxicity and long-term toxicity test: rat abdominal cavity injection acute LD50245mg/kg and a gavage of 328 mg/kg. For dogs injected with 40 mg/kg or 50mg/kg for 24 days, no bone marrow suppression is seen, and after the injection is administered with 60mg/kg for 24 days, cold tremor, contracture and no local irritation can be seen. The lotion has no adverse reaction when being used, which indicates that the lotion is safe and reliable.
Clinical research application:
clinical data: 432 hemorrhoid patients, internal hemorrhoid, external hemorrhoid, and mixed hemorrhoid were randomly divided into 218 treatment groups and 214 control groups; 230 male and 202 female.
The treatment method comprises taking a bottle of the product, diluting with hot water to 1500ml, fumigating for 3-5 min, and hip-bathing for 30 min 2 times a day. 5-7 days is 1 course of treatment, and 2-3 courses of treatment are common; taking a potassium permanganate solution with the ratio of 1: 500 in the control group, and carrying out hip bath for 1-2 times/d after defecation until the control group is healed.
The curative effect standard is that the wound has no pain, no blood and exudate, and the wound surface is healed to be obvious; the pain of the wound is relieved, the wound has little effusion and no blood seepage, and the wound surface is effectively healed; the pain of the wound is not improved, the phenomena of exudate and blood are generated on the part, and the wound surface is not healed.
The treatment results comprise that 218 patients in the treatment group have obvious effect of 96 patients and 122 patients have effect, and the total effective rate is 100 percent; 214 cases of the control group, 6 cases of significant effect, 110 cases of effect and 98 cases of no effect, and the total effective rate is 54 percent.
The present invention is not limited to the above-described embodiments, and those skilled in the art will understand that: various changes, modifications, substitutions and alterations can be made to the embodiments without departing from the principles and spirit of the invention, the scope of which is defined by the claims and their equivalents.
Claims (7)
1. The traditional Chinese medicine lotion for treating hemorrhoids is characterized by being prepared from the following raw materials in parts by weight: 400 portions of selfheal 200-.
2. The traditional Chinese medicine for treating hemorrhoids as claimed in claim 1, is characterized by being prepared from the following raw materials in parts by weight: 300 parts of selfheal, 300 parts of dandelion, 250 parts of barberry root and 300 parts of sophora flower bud.
3. The traditional Chinese medicine for treating hemorrhoids according to claims 1-2, wherein: decocting Spica Prunellae, herba Taraxaci, radix Berberidis and flos Sophorae Immaturus coarse powder in water, filtering, concentrating the decoction, adding sodium benzoate, press filtering, adding distilled water, mixing, and packaging to obtain the final product.
4. The traditional Chinese medicine for treating hemorrhoids as claimed in claim 3, wherein: decocting twice, wherein the water adding amount of each decoction is 10-11 times of the total weight of the dry medicines, and the decocting time is 1-1.5 h.
5. The traditional Chinese medicine for treating hemorrhoids as claimed in claim 4, wherein: the filtrate was concentrated to 1-1.5g per ml.
6. The traditional Chinese medicine for treating hemorrhoids as claimed in claim 5, wherein: the addition amount of the sodium benzoate is 0.4-0.6% of the weight of the concentrated solution.
7. The traditional Chinese medicine for treating hemorrhoids as claimed in claim 6, wherein: the distilled water is added according to the weight of the concentrated solution and the equal proportion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011168757.3A CN112121077A (en) | 2020-10-28 | 2020-10-28 | Traditional Chinese medicine lotion for treating hemorrhoids |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011168757.3A CN112121077A (en) | 2020-10-28 | 2020-10-28 | Traditional Chinese medicine lotion for treating hemorrhoids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112121077A true CN112121077A (en) | 2020-12-25 |
Family
ID=73853121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011168757.3A Pending CN112121077A (en) | 2020-10-28 | 2020-10-28 | Traditional Chinese medicine lotion for treating hemorrhoids |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112121077A (en) |
-
2020
- 2020-10-28 CN CN202011168757.3A patent/CN112121077A/en active Pending
Non-Patent Citations (3)
| Title |
|---|
| （清）江进纂辑；邱玏校注: "《集古良方》", 30 June 2012, 中医古籍出版社 * |
| 刘孟宇等主编: "《常用中药的拓展应用》", 31 August 2010, 人民军医出版社 * |
| 吴德峰主编: "《实用中草药》", 31 October 2017, 上海科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1883618B (en) | Effective parts of cirald daphne bark, preparation method and application thereof | |
| CN104547826A (en) | Medical application of galangin extract to treat dysmenorrhea | |
| CN104013929B (en) | Rheumatism pain relief medicine for treating rheumatic arthritis and rheumatoid arthritis and preparation method thereof | |
| CN101966250B (en) | Externally applied Chinese medicament for treating burn and manufacturing method thereof | |
| CN101829278B (en) | Quick antiphlogistic and analgesic Chinese herbal preparation | |
| CN103877281A (en) | Pharmaceutical composition for treating chicken colibacillosis, and preparation method thereof | |
| CN101843889B (en) | Medicament for treating lymphedema and venous edema and application thereof | |
| CN112121077A (en) | Traditional Chinese medicine lotion for treating hemorrhoids | |
| CN102188483B (en) | Extract for treating pharyngolaryngitis and preparation method thereof | |
| KR20150127948A (en) | Herbal composition for treating hemorrhoids | |
| CN104940307B (en) | A kind of Chinese medicine composition and purposes for preventing Nosema apis parasitosis | |
| CN113750188B (en) | Application of traditional Chinese medicine composition in preparation of medicine for treating cold | |
| CN113171404A (en) | Chinese traditional medicine hip bath lotion for treating hemorrhoids | |
| CN102688328A (en) | Chinese medicine composition for treating bovine influenza | |
| CN112773833A (en) | Traditional Chinese medicine prescription for treating recurrent aphthae and preparation method thereof | |
| CN116211933B (en) | Anticoccidial traditional Chinese medicine composition and application thereof | |
| CN113521206B (en) | Traditional Chinese medicine composition containing burdock | |
| CN103446564A (en) | Traditional Chinese medicine composition for antisepsis and antiinflammation and preparation method thereof | |
| CN118593632B (en) | Traditional Chinese medicine composition for dispelling wind, removing dampness, diminishing inflammation and relieving pain as well as preparation method and application thereof | |
| CN102727766A (en) | Traditional Chinese medicinal preparation for treating comprehensive hemorrhoids, and preparation method thereof | |
| CN113350474A (en) | Anti-inflammatory and analgesic compound traditional Chinese medicine composition as well as preparation method and application thereof | |
| Insaf et al. | PHARMACOGNOSTICAL AND PHARMACOLOGICAL ASPECTS OF BERBERIS ARISTATA | |
| Roger | Tsobou Roger1*, Hamawa Yougouda2, Fawa Guidawa3, Tatsimo Ndendoung Simplice Joël4, Avana Tientcheu Marie-Louise5, Wouokoue Taffo Junior Baudoin1, Mapongmetsem Pierre Marie3, Van Damme Patrick6 | |
| SENTHILKUMAR et al. | A review on medicinal uses of Acalypha indica linn | |
| CN105233005A (en) | Traditional Chinese medicine composition for preventing infection of skin at catheter opening of central vein indwelling catheter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201225 |